2,000
Participants
Start Date
August 22, 2022
Primary Completion Date
August 22, 2024
Study Completion Date
August 22, 2026
the clinical use of artificial intelligence in the diagnosis of prostate cancer
Each study site will enroll consecutive eligible patients and randomize them to either (a) a group with human-based interpretation or (b) a group with human-artificial intelligence interactive interpretation, both of which are utilized as standards of care.
RECRUITING
Yu-Dong Zhang, Nanjing
The First Affiliated Hospital of Soochow University
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER